Julia E Heck1, Andrew S Park1, Zuelma A Contreras1, Tom B Davidson2, Katherine J Hoggatt3, Myles Cockburn4, Beate Ritz1. 1. Department of Epidemiology, Fielding School of Public Health, University of California-Los Angeles. 2. Division of Pediatric Hematology/Oncology, Department of Pediatrics, David Geffen School of Medicine University of California-Los Angeles. 3. Department of Epidemiology, Fielding School of Public Health, University of California-Los Angeles3Veterans Affairs Greater Los Angeles, Los Angeles, California. 4. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles.
Abstract
IMPORTANCE: The Hispanic epidemiologic paradox is the phenomenon that non-US-born Hispanic mothers who immigrate to the United States have better pregnancy outcomes than their US-born counterparts. It is unknown whether this advantage extends to childhood cancer risk. OBJECTIVE: To determine whether the risk for childhood cancers among Hispanic children varies by maternal birthplace. DESIGN, SETTING, AND PARTICIPANTS: In this population-based case-control study conducted in June 2015, cohort members were identified through California birth records of children born in California from January 1, 1983, to December 31, 2011. Information on cancer diagnoses was obtained from California Cancer Registry records from 1988 to 2012. Cases (n = 13 666) were identified from among children younger than 6 years in the California Cancer Registry and matched to California birth certificates. Control children (n = 15 513 718) included all other children born in California during the same period. Maternal birthplace and ethnic ancestry were identified from the birth certificate. MAIN EXPOSURES: Maternal race/ethnicity and birthplace. MAIN OUTCOMES AND MEASURES: We used Cox proportional hazards modeling to estimate hazard ratios (HRs) of childhood cancer. RESULTS: Included in the study were 4 246 295 children of non-Hispanic white mothers (51.3% male), 2 548 822 children of US-born Hispanic mothers (51.0% male), and 4 397 703 children of non-US-born Hispanic mothers (51.0% male). Compared with children of non-Hispanic white mothers, the children of non-US-born Hispanic mothers had a reduced risk for glioma (HR, 0.50; 95% CI, 0.44-0.58), astrocytoma (HR, 0.43; 95% CI, 0.36-0.51), neuroblastoma (HR, 0.47; 95% CI, 0.40-0.54), and Wilms tumor (HR, 0.70; 95% CI, 0.59-0.82). For these cancer types, the risk estimates for children of US-born Hispanic mothers fell between those of the children of US-born white and non-US-born Hispanic mothers. Children of Mexican-born mothers had a higher risk of yolk sac tumors (HR, 1.46; 95% CI, 0.99-2.17), while children of US-born Hispanic mothers with ancestry from countries other than Mexico had a higher risk for unilateral retinoblastoma (HR, 2.03; 95% CI, 1.33-3.11). CONCLUSIONS AND RELEVANCE: For several cancers, we observed differential risk by maternal place of birth. Examining the differences in health behaviors and environment between Hispanic groups may shed light on childhood cancer etiology.
IMPORTANCE: The Hispanic epidemiologic paradox is the phenomenon that non-US-born Hispanic mothers who immigrate to the United States have better pregnancy outcomes than their US-born counterparts. It is unknown whether this advantage extends to childhood cancer risk. OBJECTIVE: To determine whether the risk for childhood cancers among Hispanic children varies by maternal birthplace. DESIGN, SETTING, AND PARTICIPANTS: In this population-based case-control study conducted in June 2015, cohort members were identified through California birth records of children born in California from January 1, 1983, to December 31, 2011. Information on cancer diagnoses was obtained from California Cancer Registry records from 1988 to 2012. Cases (n = 13 666) were identified from among children younger than 6 years in the California Cancer Registry and matched to California birth certificates. Control children (n = 15 513 718) included all other children born in California during the same period. Maternal birthplace and ethnic ancestry were identified from the birth certificate. MAIN EXPOSURES: Maternal race/ethnicity and birthplace. MAIN OUTCOMES AND MEASURES: We used Cox proportional hazards modeling to estimate hazard ratios (HRs) of childhood cancer. RESULTS: Included in the study were 4 246 295 children of non-Hispanic white mothers (51.3% male), 2 548 822 children of US-born Hispanic mothers (51.0% male), and 4 397 703 children of non-US-born Hispanic mothers (51.0% male). Compared with children of non-Hispanic white mothers, the children of non-US-born Hispanic mothers had a reduced risk for glioma (HR, 0.50; 95% CI, 0.44-0.58), astrocytoma (HR, 0.43; 95% CI, 0.36-0.51), neuroblastoma (HR, 0.47; 95% CI, 0.40-0.54), and Wilms tumor (HR, 0.70; 95% CI, 0.59-0.82). For these cancer types, the risk estimates for children of US-born Hispanic mothers fell between those of the children of US-born white and non-US-born Hispanic mothers. Children of Mexican-born mothers had a higher risk of yolk sac tumors (HR, 1.46; 95% CI, 0.99-2.17), while children of US-born Hispanic mothers with ancestry from countries other than Mexico had a higher risk for unilateral retinoblastoma (HR, 2.03; 95% CI, 1.33-3.11). CONCLUSIONS AND RELEVANCE: For several cancers, we observed differential risk by maternal place of birth. Examining the differences in health behaviors and environment between Hispanic groups may shed light on childhood cancer etiology.
Authors: Holly L Howe; Xiaocheng Wu; Lynn A G Ries; Vilma Cokkinides; Faruque Ahmed; Ahmedin Jemal; Barry Miller; Melanie Williams; Elizabeth Ward; Phyllis A Wingo; Amelie Ramirez; Brenda K Edwards Journal: Cancer Date: 2006-10-15 Impact factor: 6.860
Authors: Julia E Heck; Christina A Lombardi; Travis J Meyers; Myles Cockburn; Michelle Wilhelm; Beate Ritz Journal: Cancer Causes Control Date: 2012-07-29 Impact factor: 2.506
Authors: Rachel Eyre; Richard G Feltbower; Emmanuel Mubwandarikwa; Tim O B Eden; Richard J Q McNally Journal: Pediatr Blood Cancer Date: 2009-12 Impact factor: 3.167
Authors: Roland B Walter; Theodore M Brasky; Sarah A Buckley; John D Potter; Emily White Journal: J Natl Cancer Inst Date: 2013-05-24 Impact factor: 13.506
Authors: Kevin Y Urayama; Julie Von Behren; Peggy Reynolds; Andrew Hertz; Monique Does; Patricia A Buffler Journal: Ann Epidemiol Date: 2009-04-11 Impact factor: 3.797
Authors: Julia E Heck; Jun Wu; Christina Lombardi; Jiaheng Qiu; Travis J Meyers; Michelle Wilhelm; Myles Cockburn; Beate Ritz Journal: Environ Health Perspect Date: 2013-09-10 Impact factor: 9.031
Authors: Negar Omidakhsh; Arupa Ganguly; Greta R Bunin; Ondine S von Ehrenstein; Beate Ritz; Julia E Heck Journal: Am J Ophthalmol Date: 2017-01-26 Impact factor: 5.258
Authors: Rebecca D Kehm; Logan G Spector; Jenny N Poynter; David M Vock; Theresa L Osypuk Journal: Am J Epidemiol Date: 2018-05-01 Impact factor: 4.897
Authors: Rainbow Rubin; Michelle Pearl; Martin Kharrazi; Benjamin C Blount; Mark D Miller; Elizabeth N Pearce; Liza Valentin-Blasini; Gerald DeLorenze; Jane Liaw; Andrew N Hoofnagle; Craig Steinmaus Journal: Environ Res Date: 2017-06-09 Impact factor: 6.498
Authors: Connor Graham; Catherine Metayer; Libby M Morimoto; Joseph L Wiemels; Arfan Siddique; Mengyang Di; Rozalyn L Rodwin; Nina S Kadan-Lottick; Xiaomei Ma; Rong Wang Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-09-02 Impact factor: 4.090
Authors: Stephen S Francis; Rong Wang; Catherine Enders; Isabel Prado; Joseph L Wiemels; Xiaomei Ma; Catherine Metayer Journal: Cancer Causes Control Date: 2020-10-28 Impact factor: 2.532